Ponatinib strikingly inhibited the growth of both WT and T674I FIP1L1-PDGFRα-carrying CEL cells (IC50: 0.004–2.5 nM). Here, PDGFRA is linked to Chronic Eosinophilic Leukemia, Not Otherwise Specified.